Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for weight and depression in overweight women with mild to moderate depression
IRCT2014020316465N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in major depressive disorder (MDD) and obesity, sponsored by Tehran University of Medical Sciences. Started Aug 2014; status: completed.
02
Drugs
melatonin
03
Conditions
major depressive disorder (MDD)obesity
Beyond the preview
Go deeper on IRCT2014020316465N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014020316465N1.